Disclosures for "Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington’s Disease "
-
Mr. Shiino has nothing to disclose.
-
Mr. Kim has nothing to disclose.
-
Mr. Slaughter has received research support from National Science Foundation.
-
Miss Hay has nothing to disclose.
-
The institution of Ms. Raines has received research support from National Institute of Health.
-
Dr. Durrough has received personal compensation for serving as an employee of Vanderbilt University Medical Center.
-
Ms. Vaughn has nothing to disclose.
-
Dr. De Riesthal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alterity. The institution of Dr. De Riesthal has received research support from NIH.
-
Dr. Mefferd has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alterity. Dr. Mefferd has received research support from NIH NIDCD. Dr. Mefferd has received personal compensation in the range of $500-$4,999 for serving as a NIH grant reviewer with NIH.
-
Dr. Brown has nothing to disclose.